Turmeric and Hormone Receptor Positive Breast Cancer: A Cautionary Guide - Oncology

Share to:

Breast cancer and curcumin?


Hello, doctor.
I would like to ask if the information available online states that turmeric contains estrogen.
For patients with hormone receptor-positive conditions undergoing lactation restoration therapy, would combining turmeric affect their hormone levels? I'm unsure if turmeric can be used as a post-recovery health supplement.
Thank you.

Niming, 40~49 year old female. Ask Date: 2023/04/27

Dr. Hu Ziren reply Oncology


During the period of taking galactagogue medications, it is not recommended to consume turmeric-related dietary supplements.

Reply Date: 2023/04/27

More Info


Turmeric, particularly its active compound curcumin, has gained attention for its potential health benefits, including anti-inflammatory and antioxidant properties. However, when it comes to hormone receptor-positive breast cancer, particularly in patients undergoing treatment with medications like tamoxifen (复乳纳), caution is warranted.

Firstly, it is essential to understand what hormone receptor-positive breast cancer means. This type of cancer has cells that grow in response to hormones like estrogen. Treatments for this condition often involve hormone therapies that aim to block these hormones from promoting cancer growth. Tamoxifen, for instance, is a selective estrogen receptor modulator (SERM) that works by binding to estrogen receptors in breast tissue, thereby inhibiting the effects of estrogen on these cells.

The concern regarding turmeric arises from its reported phytoestrogenic properties. Phytoestrogens are plant-derived compounds that can mimic estrogen in the body. While some studies suggest that curcumin may have a protective effect against certain types of cancer, including breast cancer, the potential for turmeric to influence estrogen levels in hormone receptor-positive patients is not fully understood. Given that turmeric may exert estrogen-like effects, there is a theoretical risk that it could interfere with the efficacy of hormone therapies like tamoxifen.

Current clinical guidelines generally advise against the use of herbal supplements, including turmeric, during hormone therapy for breast cancer. This recommendation is primarily due to the lack of comprehensive studies confirming the safety and efficacy of such supplements in this context. The interaction between turmeric and tamoxifen could potentially lead to reduced effectiveness of the cancer treatment, which is a significant concern for patients who are already at risk for recurrence.

In addition to the potential hormonal interactions, it is crucial to consider the overall health of the patient. Patients undergoing treatment for breast cancer often have specific dietary and lifestyle recommendations tailored to their individual health needs. While turmeric is generally considered safe in culinary amounts, high doses or concentrated supplements may pose risks, especially in patients with a history of hormone-sensitive cancers.

For patients looking for complementary approaches to support their recovery, it is advisable to focus on evidence-based practices. This includes maintaining a balanced diet rich in fruits, vegetables, whole grains, and lean proteins, engaging in regular physical activity, and managing stress through mindfulness or other relaxation techniques. These lifestyle factors have been shown to support overall health and may contribute to better outcomes in cancer recovery.

In conclusion, while turmeric has potential health benefits, its use in hormone receptor-positive breast cancer patients undergoing treatments like tamoxifen should be approached with caution. It is essential for patients to discuss any supplements or dietary changes with their healthcare providers to ensure that they do not inadvertently interfere with their cancer treatment. Regular follow-ups and open communication with the healthcare team are vital for managing health during and after cancer treatment.

Similar Q&A

Understanding Breast Cancer Treatment Options: Chemotherapy vs. Hormonal Therapy

Hello, doctor. I am 32 years old and have stage II breast cancer. I have undergone a lumpectomy on my left breast. The tumor analysis shows: hormone receptor positive, HER2 negative, and Ki67 at 30%. I would like to know if I definitely need to undergo chemotherapy, or if I can b...


Dr. Lai Yicheng reply Oncology
Dear Ms. Vicky, Thank you for your inquiry. Here is my response: 1. Due to the incomplete information you provided, we can only determine that targeted therapy is not required (HER2 negative / Ki67 50%). This is insufficient to ascertain the need for chemotherapy. - Chemother...

[Read More] Understanding Breast Cancer Treatment Options: Chemotherapy vs. Hormonal Therapy


Managing Hormonal Therapy and Liver Health in Breast Cancer Patients

I apologize for the inconvenience. I would like to ask the doctor about a patient with stage I breast cancer who is hormone receptor-positive (ER and PR positive) and HER2-negative. The patient underwent surgery in December last year and has been receiving hormone therapy and rad...


Dr. Yuan Tianmin reply Breast and Thyroid
Your doctor recommends that you stop the medication and monitor your liver function before making any adjustments to the treatment. You should feel reassured, as you have just undergone surgery for stage I breast cancer, and it is unlikely to recur in such a short period of time.

[Read More] Managing Hormonal Therapy and Liver Health in Breast Cancer Patients


Managing Side Effects of Cancer Medications: A Patient's Dilemma

The patient has been taking hormonal therapy for nearly a year but can no longer tolerate the side effects, including joint pain, which is making it difficult to get out of bed. They feel as though they are on the verge of a stroke and have no energy, so they have decided to stop...


Dr. Lai Yicheng reply Oncology
According to your letter, the use of Femara has resulted in joint pain, with a reported incidence of approximately 1-10% in the literature. You are ER+3 and PR+3, indicating that hormonal therapy is highly effective for you. Therefore, I recommend discussing with your attending p...

[Read More] Managing Side Effects of Cancer Medications: A Patient's Dilemma


Understanding Breast Cancer Risk and Evening Primrose Oil: What You Need to Know

Hello, my mother had a liver tumor (which has been surgically removed) and later was diagnosed with breast cancer (which was not metastatic and has also been surgically removed). Does this indicate a potential hereditary risk for breast cancer? I read online that individuals with...


Dr. Cai Yonglong reply Obstetrics and Gynecology
Dear Mia, The term hereditary breast cancer is currently understood in the medical field as being associated with the presence of BRCA1 or BRCA2 genes. However, these genes are generally not used as screening tools since they account for a relatively small proportion of breast c...

[Read More] Understanding Breast Cancer Risk and Evening Primrose Oil: What You Need to Know


Related FAQ

Breast Cancer

(Oncology)

Uterus

(Oncology)

Fibroadenoma

(Breast and Thyroid)

Thalassemia

(Oncology)

Stomach Cancer

(Oncology)

Melanoma

(Oncology)

Cancer Diet

(Nutrition)

Liver Cancer

(Oncology)

Axillary Lump

(Oncology)

Breast Cancer

(Surgery)